NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 6.20% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.45% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.20% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.18% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.98% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.92% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.69% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.63% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 4.16% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.56% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 3.37% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.16% |